Search research articles
Contact Us
Filters
Showing results (271-280 of 454) with videos related to
Page
of 46
Sort By:
The Lancet. Diabetes & Endocrinology
|
October 7, 2021
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
Hiddo J L Heerspink, Niels Jongs, Glenn M Chertow, et al.
Environmental Science & Technology
|
August 20, 2013
Environmental determinants of polychlorinated biphenyl concentrations in residential carpet dust
Curt T DellaValle, David C Wheeler, Nicole C Deziel, et al.
Occupational and Environmental Medicine
|
November 17, 2012
Inside the black box: starting to uncover the underlying decision rules used in a one-by-one expert assessment of occupational exposure in case-control studies
David C Wheeler, Igor Burstyn, Roel Vermeulen, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Diabetes, Obesity & Metabolism
|
January 5, 2022
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease
Glenn M Chertow, Priya Vart, Niels Jongs, et al.
Trials
|
October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trial
Toby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Journal of the American Society of Nephrology : JASN
|
May 17, 2018
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
Amarnath Marthi, Killian Donovan, Richard Haynes, et al.
Clinical Kidney Journal
|
February 11, 2022
The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysis
Alexander D Lalayiannis, Charles J Ferro, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 16, 2024
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials
Robert A Fletcher, William G Herrington, Rajiv Agarwal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
Natalie Staplin, Richard Haynes, William G Herrington, et al.
Page
of 46
Search research articles
Search
Showing results (271-280 of 454) with videos related to
Sort By:
Page
of 46
The Lancet. Diabetes & Endocrinology
|
October 7, 2021
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
Hiddo J L Heerspink, Niels Jongs, Glenn M Chertow, et al.
Environmental Science & Technology
|
August 20, 2013
Environmental determinants of polychlorinated biphenyl concentrations in residential carpet dust
Curt T DellaValle, David C Wheeler, Nicole C Deziel, et al.
Occupational and Environmental Medicine
|
November 17, 2012
Inside the black box: starting to uncover the underlying decision rules used in a one-by-one expert assessment of occupational exposure in case-control studies
David C Wheeler, Igor Burstyn, Roel Vermeulen, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Diabetes, Obesity & Metabolism
|
January 5, 2022
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease
Glenn M Chertow, Priya Vart, Niels Jongs, et al.
Trials
|
October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trial
Toby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Journal of the American Society of Nephrology : JASN
|
May 17, 2018
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
Amarnath Marthi, Killian Donovan, Richard Haynes, et al.
Clinical Kidney Journal
|
February 11, 2022
The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysis
Alexander D Lalayiannis, Charles J Ferro, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 16, 2024
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials
Robert A Fletcher, William G Herrington, Rajiv Agarwal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
Natalie Staplin, Richard Haynes, William G Herrington, et al.
Page
of 46